Tuesday, February 25, 2020

Aurobindo Pharma gets EIR with VAI status from USFDA for Hyderabad facility

Aurobindo Pharma gets EIR with VAI status from USFDA for Hyderabad facility According to the US health regulator, a VAI classification "means objectionable conditions or practices were found but the agency is not prepared to take or recommend any administrative or regulatory action".

from Moneycontrol Business News https://ift.tt/32sdjPt
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

US stock: S&P 500 ends lower as investors weigh data, Middle East tensions

The S&P 500's streak came to an end, falling from its peak as weaker retail sales suggested caution among consumers. Despite a stron...